Bone Growth Induction in Mucopolysaccharidosis IVA Mouse

Bone Growth Induction in Mucopolysaccharidosis IVA Mouse

Mucopolysaccharidosis IVA (MPS IVA; Morquio A syndrome) is caused by a deficiency of the N-acetylgalactosamine-6-sulfate-sulfatase (GALNS) enzyme, leading to the accumulation of glycosaminoglycans (GAG), keratan sulfate (KS) and chondroitin-6-sulfate (C6S), mainly in cartilage and bone. This lysosom...

Full description

Bibliographic Details
Main Authors:	Estera Rintz, Angélica María Herreño-Pachón, Betul Celik, Fnu Nidhi, Shaukat Khan, Eliana Benincore-Flórez, Shunji Tomatsu
Format:	Article
Language:	English
Published:	MDPI AG 2023-06-01
Series:	International Journal of Molecular Sciences
Subjects:	C-type natriuretic peptide Morquio A syndrome ossification AAV gene therapy
Online Access:	https://www.mdpi.com/1422-0067/24/12/9890

Similar Items

Activity of daily living in mucopolysaccharidosis IVA patients: Evaluation of therapeutic efficacy
by: Hui Chen, et al.
Published: (2021-11-01)

Atypical presentation of mucopolysaccharidosis type IVA
by: Eric T. Rush
Published: (2016-09-01)

Enhanced Efficiency of the Basal and Induced Apoptosis Process in Mucopolysaccharidosis IVA and IVB Human Fibroblasts
by: Joanna Brokowska, et al.
Published: (2023-09-01)

Clinical, radiologic, and genetic features of Korean patients with Mucopolysaccharidosis IVA
by: Na Hee Lee, et al.
Published: (2012-11-01)

Mucopolysaccharidosis Type IVA: Extracellular Matrix Biomarkers in Cardiovascular Disease
by: Brittany Montavon, et al.
Published: (2022-05-01)

Determination of genotypic and clinical characteristics of Colombian patients with mucopolysaccharidosis IVA
by: Tapiero-Rodriguez SM, et al.
Published: (2018-04-01)

Role of elosulfase alfa in mucopolysaccharidosis IVA
by: Regier DS, et al.
Published: (2016-06-01)

Mucopolysaccharidosis type IVA in children: Clinical cases
by: A. V. Burlutskaya, et al.
Published: (2022-02-01)

Liver-Targeted AAV8 Gene Therapy Ameliorates Skeletal and Cardiovascular Pathology in a Mucopolysaccharidosis IVA Murine Model
by: Kazuki Sawamoto, et al.
Published: (2020-09-01)

Iron oxide-coupled CRISPR-nCas9-based genome editing assessment in mucopolysaccharidosis IVA mice
by: Andrés Felipe Leal, et al.
Published: (2023-12-01)

Molecular Mechanism of Induction of Bone Growth by the C-Type Natriuretic Peptide
by: Estera Rintz, et al.
Published: (2022-05-01)

Endoscopic and Image Analysis of the Airway in Patients with Mucopolysaccharidosis Type IVA
by: Yi-Hao Lee, et al.
Published: (2023-03-01)

Chondroitin sulfate disaccharide is a specific and sensitive biomarker for mucopolysaccharidosis type IVA
by: Sharon J. Chin, et al.
Published: (2020-09-01)

Elosulfase alfa in the treatment of mucopolysaccharidosis type IVA: insights from the first managed access agreement
by: Bob Stevens, et al.
Published: (2021-09-01)

Clinical Presentation and Follow Up of Patients with Mucopolysaccharidosis Type IVA (Morquio A Disease): Single Center Experience
by: Ebru Canda, et al.
Published: (2018-03-01)

Enzyme replacement therapy interruption in mucopolysaccharidosis type IVA patients and its impact in different clinical outcomes
by: Juan Politei, et al.
Published: (2021-03-01)

Efficacy of Intravenous Elosulfase Alfa for Mucopolysaccharidosis Type IVA: A Systematic Review and Meta-Analysis
by: Chung-Lin Lee, et al.
Published: (2022-08-01)

Clinical features and health-related quality of life in adult patients with mucopolysaccharidosis IVA: the Spanish experience
by: Pilar Quijada-Fraile, et al.
Published: (2021-11-01)

Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets
by: Andrés Felipe Leal, et al.
Published: (2022-12-01)

Sex Difference Leads to Differential Gene Expression Patterns and Therapeutic Efficacy in Mucopolysaccharidosis IVA Murine Model Receiving AAV8 Gene Therapy
by: Matthew Piechnik, et al.
Published: (2022-10-01)

Consensus statement on enzyme replacement therapy for mucopolysaccharidosis IVA in Central and South-Eastern European countries
by: Martin Magner, et al.
Published: (2022-05-01)

Oxidative profile exhibited by Mucopolysaccharidosis type IVA patients at diagnosis: Increased keratan urinary levels
by: Bruna Donida, et al.
Published: (2017-06-01)

Clinical characteristics and effects of enzyme replacement therapy with elosulfase alfa in Korean patients with mucopolysaccharidosis type IVA
by: Seung Hoon Lee, et al.
Published: (2022-06-01)

Mucopolysaccharidosis type IV: report of 5 cases of Morquio Syndrome
by: Jorge Alejandro Cadena Arteaga, MD. MSP., et al.
Published: (2022-02-01)

Case Report: Diagnosis of Mucopolysaccharidosis Type IVA With Compound Heterozygous Galactosamine-6 Sulfatase Variants and Biopsy of Replaced Femoral Heads
by: Yiyang Ma, et al.
Published: (2022-07-01)

Mucopolysaccharidosis IVA: Current Disease Models and Drawbacks
by: Andrés Felipe Leal, et al.
Published: (2023-11-01)

The GALNS p.P77R variant is a probable Gujarati-Indian founder mutation causing Mucopolysaccharidosis IVA syndrome
by: Harsh Sheth, et al.
Published: (2022-06-01)

Pathophysiology of Hip Disorders in Patients with Mucopolysaccharidosis IVA
by: Zhigang Wang, et al.
Published: (2020-04-01)

Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy
by: Yasuhiko Ago, et al.
Published: (2024-01-01)

Mucopolysaccharidosis: A case report highlighting hematological aspects of the disease
by: Rubal Jain, et al.
Published: (2019-01-01)

Cochlear implantation in a patient with mucopolysaccharidosis IVA
by: Kyoko Nagao, et al.
Published: (2019-08-01)

Roentgenographic diagnosis of mucopolysaccharidosis with particular reference to Morquio syndrome
by: umesh chandra parashari, et al.
Published: (2012-02-01)

Current Strategies for Increasing Knock-In Efficiency in CRISPR/Cas9-Based Approaches
by: Andrés Felipe Leal, et al.
Published: (2024-02-01)

Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance
by: Mehmet Umut Akyol, et al.
Published: (2019-06-01)

Common N-acetylgalactosamine-6-sulfate sulfatase (GALNS) exon mutations in Brazilian patients with mucopolysaccharidosis IVA (MPS IVA)
by: Tatiana Dieter, et al.
Published: (2007-01-01)

Modeling Morquio A Syndrome: An Anthropometric Study of Body Characteristics and Stature
by: Agnieszka Różdżyńska-Świątkowska, et al.
Published: (2020-02-01)

Natural history of Morquio A patient with tracheal obstruction from birth to death
by: Caitlin Doherty, et al.
Published: (2018-03-01)

Automated Assessment of Thoracic-Abdominal Asynchrony in Patients with Morquio Syndrome
by: Madhavi V. Ratnagiri, et al.
Published: (2021-05-01)

Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA
by: Yasutsugu Chinen, et al.
Published: (2014-01-01)

Contribución Colombiana al Conocimiento de la Enfermedad de Morquio A
by: Carlos Javier Alméciga Díaz, et al.
Published: (2012-07-01)